Bcl-xL
[1]. Sajid Khan, et al. A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity. Nat Med 25, 1938–1947 (2019).
陜西締都醫(yī)藥有限責任公司
聯系商家時請?zhí)峒癱hemicalbook,有助于交易順利完成!